Kyoungwon Jung

Kyoungwon Jung

Auto-generated profile, based on publicly available information

Kyoungwon Jung

Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
HJHye-Kyung Jung
Hye-Kyung Jung
SHSu Jin Hong
Su Jin Hong
YLYong Chan Lee
Yong Chan Lee
JPJohn Pandolfino
John Pandolfino
HPHyojin Park
Hyojin Park
KMKorean Society Of Neurogastroenterology And Motility
Korean Society Of Neurogastroenterology And Motility
Hye-Kyung Jung, Su Jin Hong, Oh Young Lee, John Pandolfino, Hyojin Park, Hiroto Miwa, Uday C Ghoshal, Sanjiv Mahadeva, Tadayuki Oshima, Minhu Chen, Andrew S B Chua, Yu Kyung Cho, Tae Hee Lee, Yang Won Min, Chan Hyuk Park, Joong Goo Kwon, Moo In Park, Kyoungwon Jung, Jong Kyu Park, Kee Wook Jung, Hyun Chul Lim, Da Hyun Jung, Do Hoon Kim, Chul-Hyun Lim, Hee Seok Moon, Jung Ho Park, Suck Chei Choi, Hidekazu Suzuki, Tanisa Patcharatrakul, Justin C Y Wu, Kwang Jae Lee, Shinwa Tanaka, Kewin T H Siah, Kyung Sik Park, and Sung Eun Kim; The Korean Society of Neurogastroenterology and Motility. J Neurogastroenterol Motil 2020;26:180-203. https://doi.org/10.5056/jnm20014

30 January 2020 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
JOJung Hwan Oh
Jung Hwan Oh
JKJoong Goo Kwon
Joong Goo Kwon
HJHye-Kyung Jung
Hye-Kyung Jung
CTChung Hyun Tae
Chung Hyun Tae
KSKyung Ho Song
Kyung Ho Song
MOMotility
Motility
Jung Hwan Oh, Joong Goo Kwon, Hye-Kyung Jung, Chung Hyun Tae, Kyung Ho Song, Seung Joo Kang, Sung Eun Kim, Kyoungwon Jung, Joon Sung Kim, Jong Kyu Park, Ki Bae Bang, Myong Ki Baeg, Jeong Eun Shin, Cheol Min Shin, Ju Yup Lee, and Hyun Chul Lim; Functional Dyspepsia Research Group and Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility. J Neurogastroenterol Motil 2020;26:29-50. https://doi.org/10.5056/jnm19209

30 July 2016 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
KJKyoungwon Jung
Kyoungwon Jung
MPMoo In Park
Moo In Park
SKSung Eun Kim
Sung Eun Kim
SPSeun Ja Park
Seun Ja Park
Early diagnosis of Borrmann type 4 advanced gastric cancer (AGC) is very important for improving the prognosis of AGC patients. Because there is no definite mass in most cases of Borrmann type 4 AGC, its accurate diagnosis via endoscopy requires an understanding of its pathogenesis and developmental process. Moreover, many people confuse linitis plastica (LP) type gastric cancer (GC), scirrhous GC, and Borrmann type 4 AGC. To distinguish each of these cancers, knowledge of their endoscopic and pathological differences is necessary, especially for LP type GCs in the developmental stage. In conclusion, diagnosis of pre-stage or latent LP type GC before progression to typical LP type GC requires the detection of IIc-like lesions in the fundic gland area. It is also crucial to identify any abnormalities such as sclerosis of the gastric wall and hypertrophy of the mucosal folds during endoscopy.

16 February 2019 in World Journal of Gastrointestinal Endoscopy
Verified
Journal Article
Open access
KJKyoungwon Jung
Kyoungwon Jung
WMWon Moon
Won Moon
Although upper gastrointestinal bleeding is usually segregated from lower gastrointestinal bleeding, and guidelines for gastrointestinal bleeding are divided into two separate sections, they may not be distinguished from each other in clinical practice. Most patients are first observed with signs of bleeding such as hematemesis, melena, and hematochezia. When a patient with these symptoms presents to the emergency room, endoscopic diagnosis and treatment are considered together with appropriate initial resuscitation. Especially, in cases of variceal bleeding, it is important for the prognosis that the endoscopy is performed immediately after the patient stabilizes. In cases of suspected lower gastrointestinal bleeding, full colonoscopy after bowel preparation is effective in distinguishing the cause of the bleeding and treating with hemostasis. The therapeutic aspect of endoscopy, using the mechanical method alone or injection with a certain modality rather than injection alone, can increase the success rate of bleeding control. Therefore, it is important to consider the origin of bleeding and how to approach it. In this article, we aim to review the role of endoscopy in diagnosis, treatment, and prognosis in patients with acute gastrointestinal bleeding in a real clinical setting.

5 January 2021 in Helicobacter
Verified
Journal Article
Closed access
PDF file
KJKyoungwon Jung
Kyoungwon Jung
DKDo Hoon Kim
Do Hoon Kim
HSHyun Il Seo
Hyun Il Seo
EGEun Jeong Gong
Eun Jeong Gong
Chang Seok BangChang Seok Bang
Chang Seok Bang

19 August 2022 in Medicine
Verified
Journal Article
Open access
SKSu Jin Kim
Su Jin Kim
SJSam Ryong Jee
Sam Ryong Jee
MPMoo In Park
Moo In Park
KJKyoungwon Jung
Kyoungwon Jung
Gwang Ha KimGwang Ha Kim
Gwang Ha Kim
MKMyeongseok Koh
Myeongseok Koh
Background: Increasing clarithromycin resistance has led to changes in several guidelines for treatment of Helicobacter pylori infections. We compared the H. pylori eradication rates of the empirical concomitant therapy (CoT) and a tailored therapy (TaT) using dual-priming oligonucleotide-based polymerase chain reaction to detect mutations in the 23S rRNA gene that are related to clarithromycin resistance. Methods: Between June 2020 and May 2021, 290 patients were enrolled and randomly assigned to 2 groups. In the CoT group, the patients received rabeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg twice daily for 14 days. In the TaT group, point mutation-negative patients received rabeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg twice daily for 14 days and point mutation-positive patients received rabeprazole 20 mg twice daily, metronidazole 500 mg thrice daily, and bismuth 120 mg and tetracycline 500 mg 4 times daily for 14 days. Results: A total of 290 and 261 patients were included in the intention-to-treat (ITT) and per-protocol (PP) analyses, respectively. A2142G and/or A2143G point mutations were identified in 28.6% of the patients. No significant difference in eradication rates were observed between the 2 groups as per ITT (CoT, 82.8% and TaT, 85.5%, P = .520) and PP (CoT, 88.6% and TaT, 94.6%, P = .084) analyses. In point mutation-positive patients, the eradication rates in the CoT group were lower than those in the TaT group as per ITT (69.8% and 87.5%, respectively, P = .050) and PP (76.9% and 97.1%, respectively, P = .011) analyses. Conclusion: CoT and TaT showed similar overall eradication rates for H. pylori. However, CoT eradication rate was suboptimal, especially in point mutation-positive patients.